MANCIA GIUSEPPE

Ruolo:
Professore emerito

Pubblicazioni

  • Manolis, A., Karakasis, P., Patoulias, D., Doumas, M., Kallistratos, M., Thomopoulos, C., et al. (2025). Effect of nebivolol monotherapy or combination therapy on blood pressure levels in patients with hypertension: an updated systematic review and multilevel meta-analysis of 91 randomized controlled trials. HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 32(1), 7-31 [10.1007/s40292-024-00687-5]. Dettaglio

  • Massabò, D., Quarti-Trevano, F., Seravalle, G., Facchetti, R., Dell'Oro, R., Tsioufis, K., et al. (2025). FAILURE OF ANTIHYPERTENSIVE TREATMENT TO RESTORE NORMAL SYMPATHETIC ACTIVITY. JOURNAL OF HYPERTENSION, 43(S1), 214-214 [10.1097/01.hjh.0001117400.59486.c3]. Dettaglio

  • Quarti-Trevano, F., Facchetti, R., Cuspidi, C., Mancia, G., Grassi, G. (2025). Habitual coffee consumption and risk of cardiovascular and all-cause mortality in the PAMELA hypertensive population. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 35(5) [10.1016/j.numecd.2024.10.014]. Dettaglio

  • Quarti-Trevano, F., Seravalle, G., Facchetti, R., Tsioufis, K., Dimitriadis, K., Manta, E., et al. (2025). Failure of Antihypertensive Treatment to Restore Normal Sympathetic Activity. HYPERTENSION, 82(6), 1024-1034 [10.1161/HYPERTENSIONAHA.124.24429]. Dettaglio

  • Mancia, G., Grassi, G., Kjeldsen, S. (2025). When should antihypertensive drug treatment be started? Discrepancies between the 2023 European Society of Hypertension and the 2024 European Society of Cardiology guidelines. ITALIAN JOURNAL OF MEDICINE, 19(2) [10.4081/itjm.2025.1981]. Dettaglio

Progetti di ricerca

EU-MASCARA-Markers for Sub-Clinical Cardiovascular Risk Assessemnt
Anno: 2011
Bando: 2011-014 - HEALTH.2011.2.4.2-2
Enti finanziatori: UNIONE EUROPEA
Network Enabled Drug Design
Anno: 2009
Bando: 2009-007 - Bando Fondo per la promozione di accordi istituzionali, Bando accordi istituzionali
Integrating Genomics, clinical Research and care Hypertension
Anno: 2005
Bando: FP6-LIFESCIHEALTH Life sciences, genomics and biotechnology for health,LSH-2005-2.1.1-2 Hypertension and cardiovascular disease